Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.
Mangu Srinivas BharadwajSanjana BallalChandrasekhar BalPublished in: The Journal of clinical endocrinology and metabolism (2024)
The study suggests that a maximum CA of up to 1000mCi strikes a favorable balance between keeping AEs low and benefiting a subset of patients with extensive metastases showing intense I-131 concentration.